Publication | Open Access

Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non–small-cell lung cancer

Radiation MedicineRadiation TherapyThree-dimensional Conformal RadiotherapyMedicinePhase Ii StudyCancer TreatmentOncologyRadiation OncologyLung CancerCisplatin ChemotherapyRadiologyHealth Sciences